Even BRCA1, which is obviously associated with the HRD phenotype in breast or ovarian cancer, does not necessarily undergo second-hit inactivation in pancreatic or prostate carcinomas [51,52]. The gene discussed is BRCA1; the disease is prostate carcinoma.